The drug also showed a manageable safety profile, with just 6.4% of patients stopping treatment due to side effects. No new safety concerns emerged
The initial consideration for the transaction is US$ 12 million
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Subscribe To Our Newsletter & Stay Updated
